| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | President, Chief Medical Officer, Executive Chair, Director | Common Stock | 873,978 | 05 Feb 2026 | Direct | ||
| SpyGlass Pharma, Inc. | President, Chief Medical Officer, Executive Chair, Director | Stock Option (right to buy) | 105,000 | 05 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 1 | $0 | 4 | President, Chief Medical Officer, Executive Chair, Director | 09 Feb 2026, 16:41 |
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 0 | $0 | 3 | President, Chief Medical Officer, Executive Chair Exhibit 24 - Power of Attorney, Director | 05 Feb 2026, 13:01 |